NewHydrogen, Inc.
For the period ended Jun 30, 2025. Filed Aug 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 13, 2025
NEWHStored price and day change unavailable
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-03-31; filed 2025-05-09.
0001641172-25-009465
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSCurrent report: 10-Q
Period ended 2025-06-30; filed 2025-08-13.
0001641172-25-023511
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 43 previous paragraphs and 57 current paragraphs.
32 unchanged; 10 reworded; 12 added; 1 removed; 0 previous and 3 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (12)
Current report
General and administrative (“G&A”) expenses increased by $102,209 to $381,053 for the three months ended June 30, 2025, compared to $278,844 for the prior period ended June 30, 2024. The primary increase overall was an increase in professional fees of $56,534, an increase in non-cash stock compensation of $18,108, and an overall decrease in other expenses.
Current report
Results of Operations – Six months ended June 30, 2025, compared to the Six months ended June 30, 2024.
Current report
OPERATING EXPENSES
Current report
Selling and Marketing Expenses
Current report
General and Administrative Expenses
Current report
General and administrative (“G&A”) expenses increased by $63,258 to $648,506 for the six months ended June 30, 2025, compared to $585,248 for the prior period ended June 30, 2024. The primary increase overall was an increase in professional fees of $56,534, an increase in non-cash stock compensation of $18,108, and an overall decrease in other expenses.
Current report
Research and Development
Current report
Research and Development (“R&D”) expenses increased by $71,507 to $249,385 for the six months ended June 30, 2025, compared to $177,878 for the prior period ended June 30, 2024. This increase in R&D expenses was the result of an increase in outside research fees of $22,407 and consultant cost of $47,000, overall increase in materials and supplies of $2100.
Current report
Depreciation and Amortization Expense
Current report
Depreciation and amortization expense for the six months ended June 30, 2025 and 2024 was $1,641 and $2,054, respectively.
Current report
Other Income/(Expenses)
Removed paragraphs (1)
Previous report
General and administrative (“G&A”) expenses decreased by $249 to $267,453 for the three months ended March 31, 2025, compared to $306,404 for the prior period ended March 31, 2024. The overall decrease in G&A expenses was the combination of all expenses.
Reworded paragraphs (10)
Previous wording
Management reviewed currently issued pronouncements during the three months ended March 31, 2025, and does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed unaudited financial statements.
Current wording
Management reviewed currently issued pronouncements during the six months ended June 30, 2025, and does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed unaudited financial statements.
Previous wording
Selling and marketing (“S&M”) expenses increased by $31,508 to $106,479 for the three months ended March 31, 2025, compared to $74,971 for the prior period ended March 31, 2024. The primary increase in (S&M) expenses was the result of an increase in service providers of $31,508.
Current wording
Selling and marketing (“S&M”) expenses increased by $23,863 to $94,092 for the three months ended June 30, 2025, compared to $70,229 for the prior period ended June 30, 2024. The primary increase in (S&M) expenses was the result of an increase in service providers.
Previous wording
Research and Development (“R&D”) expenses increased by $12,579 to $101,518 for the three months ended March 31, 2025, compared to $88,939 for the prior period ended March 31, 2024. This overall increase in R&D expenses was the result of an increase in outside research fees.
Current wording
Research and Development (“R&D”) expenses increased by $58,928 to $147,867 for the three months ended June 30, 2025, compared to $88,939 for the prior period ended June 30, 2024. This overall increase of $56,828 in R&D expenses was the result of an increase in outside research fees and consultant cost.
Previous wording
Depreciation and amortization expense for the three months ended March 31, 2025 and 2024 was $821 and $1,027, respectively.
Current wording
Depreciation and amortization expense for the three months ended June 30, 2025 and 2024 was $820 and $1,027, respectively.
Previous wording
Other income and (expenses) decreased by $160 to $177 for the three months ended March 31, 2025, compared to $337 for the prior period ended March 31, 2024. The decrease in other income and (expenses) was the result of an increase in interest income of $160. The decrease in other income and (expenses) was primarily due to the net change in interest income.
Current wording
Other income and (expenses) decreased by $169 to $128 for the three months ended June 30, 2025, compared to $297 for the prior period ended June 30, 2024. The decrease in other income and (expenses) was the result of an increase in interest income of $169. The decrease in other income and (expenses) was primarily due to the net change in interest income.
Previous wording
Our net loss for the three months ended March 31,2025 was $476,094, compared to $471,004 for the prior period ended March 31,2024. The Company has not generated any revenues. The majority of the decrease in net loss was due to an overall decrease in operating expenses and non-cash expense associated with the net change in stock option expense in the current period. These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the stock options fluctuate, and the fluctuation may be material. The Company has not generated any revenues.
Current wording
Our net loss for the three months ended June 30,2025 was $623,704, compared to $438,742 for the prior period ended June 30,2024. The Company has not generated any revenues. The majority of the decrease in net loss was due to an overall decrease in operating expenses and non-cash expense associated with the net change in stock option expense in the current period. These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the stock options fluctuate, and the fluctuation may be material. The Company has not generated any revenues.
Previous wording
The unaudited condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed financial statements do not reflect any adjustments that might result if we are unable to continue as a going concern. During the three months ended March 31, 2025, we did not generate any revenues, and recognized a net loss of $476,094, due to a change in operating expenses and cash of $492,812 used in operations. As of March 31, 2025, we had working capital of $1,643,210 and a shareholders’ deficit of $1,784,321.
Current wording
The unaudited condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed financial statements do not reflect any adjustments that might result if we are unable to continue as a going concern. During the six months ended June 30, 2025, we did not generate any revenues, and recognized a net loss of $1,099,798, due to a change in operating expenses and cash of $1,100,906 used in operations. As of June 30, 2025, we had working capital of $1,150,677 and a shareholders’ deficit of $179,042,345.
Previous wording
As of March 31, 2025, we had working capital of $1,643,210 compared to $2,118,257 for the year ended December 31, 2024. This decrease in working capital was due primarily to a decrease in cash.
Current wording
As of June 30, 2025, we had working capital of $1,150,677 compared to $2,102,308 for the year ended December 31, 2024. This decrease in working capital was due primarily to a decrease in cash.
Previous wording
During the three months ended March 31, 2025, we used $492,812 of cash for operating activities, as compared to $431,405 for the prior period ended March 31, 2024. The increase in the use of cash for operating activities for the current period was a result of an increase in research and development cost, and advertising and marketing.
Current wording
During the six months ended June 30, 2025, we used $1,003,615 of cash for operating activities, as compared to $824,205 for the prior period ended June 30, 2024. The increase in the use of cash for operating activities for the current period was a result of an increase in research and development cost, and advertising and marketing.
Previous wording
Net cash provided from equity financing activities for the three months ended March 31, 2025 and March 31, 2024 was $0. There was no equity financing during the current or prior period. Our capital needs have primarily been met from the proceeds of the sale of our securities, as we currently have not generated any revenues.
Current wording
Net cash provided from equity financing activities for the six months ended June 30, 2025 and June 30, 2024 was $0. There was no equity financing during the current or prior period. Our capital needs have primarily been met from the proceeds of the sale of our securities, as we currently have not generated any revenues.
Rearranged current paragraphs (3)
Current report — wording carried from elsewhere
Selling and marketing (“S&M”) expenses increased by $55,371 to $200,571 for the six months ended June 30, 2025, compared to $145,200 for the prior period ended June 30, 2024. The primary increase in (S&M) expenses was the result of an increase in service providers
Current report — wording carried from elsewhere
Other income and (expenses) decreased by $329 to $305 for the six months ended June 30, 2025, compared to $634 for the prior period ended June 30, 2024. The decrease in other income and (expenses) was the result of an increase in interest income of $169. The decrease in other income and (expenses) was primarily due to the net change in interest income.
Current report — wording carried from elsewhere
Our net loss for the six months ended June 30,2025 was $1,099,798, compared to $909,746 for the prior period ended June 30,2024. The Company has not generated any revenues. The majority of the decrease in net loss was due to an overall decrease in operating expenses and non-cash expense associated with the net change in stock option expense in the current period. These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the stock options fluctuate, and the fluctuation may be material. The Company has not generated any revenues.